CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 123 filers reported holding CLOVIS ONCOLOGY INC in Q2 2016. The put-call ratio across all filers is 1.45 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $12,146,000 | -39.9% | 10,206,509 | -9.1% | 0.00% | -100.0% |
| Q2 2022 | $20,202,000 | -19.0% | 11,223,237 | -9.1% | 0.00% | 0.0% |
| Q1 2022 | $24,945,000 | -9.0% | 12,348,898 | +22.1% | 0.00% | 0.0% |
| Q4 2021 | $27,412,000 | -50.0% | 10,115,101 | -17.7% | 0.00% | 0.0% |
| Q3 2021 | $54,835,000 | -4.6% | 12,294,891 | +24.0% | 0.00% | 0.0% |
| Q2 2021 | $57,502,000 | +7.4% | 9,914,068 | +30.1% | 0.00% | 0.0% |
| Q1 2021 | $53,516,000 | +74.5% | 7,623,193 | +19.3% | 0.00% | 0.0% |
| Q4 2020 | $30,661,000 | -14.9% | 6,387,554 | +3.3% | 0.00% | 0.0% |
| Q3 2020 | $36,044,000 | -14.5% | 6,182,479 | -1.0% | 0.00% | 0.0% |
| Q2 2020 | $42,153,000 | +48.7% | 6,244,924 | +40.1% | 0.00% | 0.0% |
| Q1 2020 | $28,348,000 | -35.5% | 4,457,259 | +5.7% | 0.00% | 0.0% |
| Q4 2019 | $43,976,000 | +147.9% | 4,218,344 | -6.5% | 0.00% | 0.0% |
| Q3 2019 | $17,740,000 | -74.0% | 4,513,843 | -1.5% | 0.00% | -66.7% |
| Q2 2019 | $68,132,000 | -40.7% | 4,581,793 | -1.0% | 0.00% | -40.0% |
| Q1 2019 | $114,911,000 | +40.3% | 4,629,762 | +1.5% | 0.01% | +25.0% |
| Q4 2018 | $81,913,000 | -37.3% | 4,560,930 | +2.6% | 0.00% | -20.0% |
| Q3 2018 | $130,551,000 | -33.9% | 4,445,064 | +2.4% | 0.01% | -37.5% |
| Q2 2018 | $197,359,000 | -6.4% | 4,340,409 | +8.7% | 0.01% | -11.1% |
| Q1 2018 | $210,745,000 | -21.0% | 3,991,378 | +1.8% | 0.01% | -25.0% |
| Q4 2017 | $266,693,000 | -16.4% | 3,921,952 | +1.3% | 0.01% | -20.0% |
| Q3 2017 | $318,955,000 | -5.9% | 3,870,805 | +7.0% | 0.02% | -11.8% |
| Q2 2017 | $338,831,000 | +62.0% | 3,618,843 | +10.2% | 0.02% | +54.5% |
| Q1 2017 | $209,169,000 | +79.6% | 3,285,195 | +25.3% | 0.01% | +83.3% |
| Q4 2016 | $116,479,000 | +28.0% | 2,622,226 | +3.9% | 0.01% | +20.0% |
| Q3 2016 | $91,007,000 | +175.8% | 2,524,464 | +4.9% | 0.01% | +150.0% |
| Q2 2016 | $33,003,000 | -23.1% | 2,405,468 | +7.7% | 0.00% | -33.3% |
| Q1 2016 | $42,902,000 | -45.1% | 2,234,421 | +0.1% | 0.00% | -40.0% |
| Q4 2015 | $78,164,000 | -88.9% | 2,233,268 | -82.9% | 0.01% | -80.8% |
| Q3 2015 | $703,729,000 | +345.0% | 13,059,146 | +625.7% | 0.03% | +136.4% |
| Q2 2015 | $158,133,000 | +29.3% | 1,799,421 | +9.2% | 0.01% | +37.5% |
| Q1 2015 | $122,305,000 | +56.2% | 1,647,649 | +17.9% | 0.01% | +33.3% |
| Q4 2014 | $78,277,000 | +27.8% | 1,397,792 | +3.5% | 0.01% | +20.0% |
| Q3 2014 | $61,237,000 | +10.1% | 1,350,007 | +0.5% | 0.01% | +25.0% |
| Q2 2014 | $55,620,000 | -38.7% | 1,343,141 | +2.5% | 0.00% | -50.0% |
| Q1 2014 | $90,749,000 | +19.9% | 1,310,076 | +4.3% | 0.01% | +14.3% |
| Q4 2013 | $75,714,000 | +20.6% | 1,256,258 | +21.6% | 0.01% | +16.7% |
| Q3 2013 | $62,789,000 | +26.0% | 1,033,042 | +38.9% | 0.01% | +20.0% |
| Q2 2013 | $49,826,000 | – | 743,888 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |